The COVID-19 pandemic is first and foremost a health crisis and humanitarian tragedy, impacting several thousands of people. In addition, it is an inevitable reshaping of the global economy. The healthcare industry, being in the front line of the pandemic, is comprehending not only the infection per se, but also consumers’ behavior patterns. The ongoing pandemic has led to a renewed emphasis on personal protective equipment (PPE) for healthcare personnel.
COVID-19 Pandemic Bolstering Sales of Respirator Mask Particulate
PPEs such as respirator mask particulate, in particular, are what healthcare personnel bank on to shield themselves from contracting COVID-19. Concerns associated with the pandemic are translating to surging demand for masks - surgical masks, and respirator mask particulate. This demand growth will gain momentum, as the pandemic continues to spread swiftly across continents. Combined, such trends are expected to influence the global market performance of respirator mask particulate in capital markets over the years ahead.
Healthcare Professionals at the Epicenter
The COVID-19 pandemic, or SARS-CoV2, has been creating massive business opportunities for respirator mask particulate manufacturers and sellers. The sales of respirator mask particulate have been swelling all over the world. The demand is reaching new heights, such that many market players are running short of supply or are restricting the number of respirator mask particulate that customers can purchase.
However, this is creating a dire situation as manufacturers are failing to meet the demand for healthcare professionals, who need respirator mask particulate to address all sorts of patients; not only those suffering from the novel coronavirus, but also those affected with other pathogens such as Mycobacterium tuberculosis (MTB). Respirator mask particulate are not available in abundance and for cheap, instead, they are in severe shortfall.
If doctors and nurses are not provided with sufficient supplies of proper respirator mask particulate, they could end up getting infected and spreading all kinds of microbes. And this a big no-no for everyone. As such, it is quintessential to understand the immediate customers of respirator mask particulate, that is, the healthcare professionals. If the general public deplete respirator mask particulate by purchasing all of it even though it is not necessary, they might be bringing healthcare professionals closer to the vicinity of the COVID-19.
Government Agencies Instrumental in Shaping Adoption
The Centers for Disease Controls and Prevention (CDC) declared a warning of probable coronavirus outbreaks in the US, triggering people to stumble upon medical supplies shops and websites looking for respirator mask particulate to protect themselves. Yet, at present, the CDC is only recommending individuals who are infected by the COVID-19 and healthcare personnel or people looking after them to wear respirator mask particulate, as the transmission rate in the U.S. is low and there is no active transmission between communities.
The public health institute has suggested that people should only wear a respirator mask particulate if they themselves are affected by the novel coronavirus or if they are caring for someone who might be infected. Else, they are simply depleting supplies for those individuals, healthcare professionals in particular, who might actually need respirator mask particulate.
Although the CDC has also mentioned that respirator mask particulate is just one of the factors for disease prevention and advises the general public to follow preventive measures including, washing the hands properly, avoid touching the face, and covering a cough or a sneeze with a tissue. In addition to this, with regard to reusing respirator mask particulate, the health protection agency permits for restricted reuse under specific conditions.
The Food and Drug Administration (FDA) is playing a big part in protecting the US from the wrath of the COVID-19, and is dedicated to providing timely guidelines to uphold remedial measures to combat this pandemic. The federal agency is implementing these guidelines to form a policy to aid extend the availability of general-use face masks for the general public and respirator mask particulate (N95) for healthcare professionals during this pandemic.
Majority of the N95 respirator mask particulate in the US are manufactured and distributed for industrial and construction applications instead of healthcare. In an effort to elevate the supply of respirator mask particulate for healthcare professionals, the FDA has issued an emergency CDC request to enable the adoption of NIOSH-approved industrial respirator mask particulate during the COVID-19 pandemic. These respiratory devices are not required to meet FDA requisites for healthcare purposes.
Possible Negatives of Wearing Respirator Mask Particulate
The evidence regarding the kind of protection respirator mask particulate will deliver in the long run is still uncertain. Healthcare professionals usually prefer N95 respirator mask particulate for a short-term duration such as entering infected patients’ ward, as wearing these masks can make it quite difficult for them to breathe. Additionally, they often replace their respirators with new ones, given the respirator mask particulate gradually degrade with time, particularly when they are wet or soiled.
People having an existing respiratory disorder such as asthma, or chronic obstructive pulmonary disease (COPD) are strictly advised to have a word with their doctors before wearing respirator mask particulate. As previously mentioned, the N95 respirator mask particulate can make it more challenging for people to breathe, even if they believe they are usually good at breathing. As such, the National Institute for Occupational Safety and Health (NIOSH) suggests that people having lung disorders, the geriatric cohort, or those having claustrophobia might struggle with respirator mask particulate.
Addressing the Challenge of Counterfeiting Activities
Surging demand for respirator mask particulate has also paved the way for counterfeit products. For instance, PPE manufacturer 3M Company has witnessed an uptick in counterfeiting activities in relation to the COVID-19 pandemic. Certain enterprises and individuals who are not authorized dealers or suppliers have falsely represented themselves as associated with 3M and are selling counterfeit 3M products.
3M has recorded incidents of respirator mask particulate being distributed individually or in bulk boxes or bags without the 3M labeling. These counterfeit masks have also been distributed with missing straps, blocked valves, strange odors, and misspelled words, thereby hitting the revenue growth of respirator mask particulate manufacturers.
Report Highlights: Global Respirator Mask Particulate Market
- An in-depth overview of parent market, covering PPE markets and respirator mask particulate market
- An overview of evolving market dynamics in the respirator mask particulate industry
- Detailed segmentation of respirator mask particulate market
- Historical, current, and prospective examination of market size in terms of value and volume
- Recent developments and influential trends in respirator mask particulate
- Opportunity assessment of respirator mask particulate market
- Competitive landscape analysis of respirator mask particulate marketplace
- Key player developments in recent times to treat COVID-19 patients
- Niche and potential segments in respirator mask particulate market that reflect promising immediate opportunities
- A neutral perspective on the entire market performance
- Must-have insights for existing and potential respirator mask particulate market players
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.